Style | Citing Format |
---|---|
MLA | Maghsoudinia F, et al.. "Bevacizumab and Folic Acid Dual-Targeted Gadolinium-Carbon Dots for Fluorescence/Magnetic Resonance Imaging of Hepatocellular Carcinoma." Journal of Drug Delivery Science and Technology, vol. 61, no. , 2021, pp. -. |
APA | Maghsoudinia F, Tavakoli MB, Samani RK, Motaghi H, Hejazi SH, Mehrgardi MA (2021). Bevacizumab and Folic Acid Dual-Targeted Gadolinium-Carbon Dots for Fluorescence/Magnetic Resonance Imaging of Hepatocellular Carcinoma. Journal of Drug Delivery Science and Technology, 61(), -. |
Chicago | Maghsoudinia F, Tavakoli MB, Samani RK, Motaghi H, Hejazi SH, Mehrgardi MA. "Bevacizumab and Folic Acid Dual-Targeted Gadolinium-Carbon Dots for Fluorescence/Magnetic Resonance Imaging of Hepatocellular Carcinoma." Journal of Drug Delivery Science and Technology 61, no. (2021): -. |
Harvard | Maghsoudinia F et al. (2021) 'Bevacizumab and Folic Acid Dual-Targeted Gadolinium-Carbon Dots for Fluorescence/Magnetic Resonance Imaging of Hepatocellular Carcinoma', Journal of Drug Delivery Science and Technology, 61(), pp. -. |
Vancouver | Maghsoudinia F, Tavakoli MB, Samani RK, Motaghi H, Hejazi SH, Mehrgardi MA. Bevacizumab and Folic Acid Dual-Targeted Gadolinium-Carbon Dots for Fluorescence/Magnetic Resonance Imaging of Hepatocellular Carcinoma. Journal of Drug Delivery Science and Technology. 2021;61():-. |
BibTex | @article{ author = {Maghsoudinia F and Tavakoli MB and Samani RK and Motaghi H and Hejazi SH and Mehrgardi MA}, title = {Bevacizumab and Folic Acid Dual-Targeted Gadolinium-Carbon Dots for Fluorescence/Magnetic Resonance Imaging of Hepatocellular Carcinoma}, journal = {Journal of Drug Delivery Science and Technology}, volume = {61}, number = {}, pages = {-}, year = {2021} } |
RIS | TY - JOUR AU - Maghsoudinia F AU - Tavakoli MB AU - Samani RK AU - Motaghi H AU - Hejazi SH AU - Mehrgardi MA TI - Bevacizumab and Folic Acid Dual-Targeted Gadolinium-Carbon Dots for Fluorescence/Magnetic Resonance Imaging of Hepatocellular Carcinoma JO - Journal of Drug Delivery Science and Technology VL - 61 IS - SP - EP - PY - 2021 ER - |